Clinical Trial Update: ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis

View source ↗

Summary

ADAPT Forward is a master protocol platform study sponsored by argenx to evaluate the safety and efficacy of multiple regimens in participants with generalized …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Snippet

Sponsor: argenx | Conditions: Myasthenia Gravis, MG | Status: RECRUITING